Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Low-dose oral contraception and bone density].

U Karck1, M Breckwoldt

  • 1Universitätsklinikum Freiburg, Abteilung Gynäkologie und Geburtshilfe II.

Therapeutische Umschau. Revue Therapeutique
|October 12, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Cerebral MR imaging of malignant melanoma].

Der Radiologe·2015
Same author

Cycle control, tolerability, efficacy and acceptability of the vaginal contraceptive ring, NuvaRing: results of clinical experience in Germany.

The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception·2007
Same author

Efficacy and safety of a low-dose 21-day combined oral contraceptive containing ethinylestradiol 20microg and drospirenone 3mg.

Clinical drug investigation·2006
Same author

[Hystero-salpingo-contrast-sonography with 3-d-ultrasound -- a pilot study].

Ultraschall in der Medizin (Stuttgart, Germany : 1980)·2004
Same author

[Hormone use in migraine].

Deutsche medizinische Wochenschrift (1946)·2003
Same author

[Is radiotherapy indicated for ductal carcinoma of the breast?].

Deutsche medizinische Wochenschrift (1946)·2003

Low-dose oral contraceptives (OC) with Ethinyl-Estradiol (EE) may affect bone remodeling. Progestagen-only pills might be a safer alternative for adolescents to ensure peak bone mass development.

Area of Science:

  • Endocrinology
  • Bone Metabolism
  • Reproductive Health

Context:

  • Oral contraceptives (OC) containing 20 or 30 mcg Ethinyl-Estradiol (EE) are widely used for contraception.
  • Concerns exist regarding the potential impact of low-dose EE on bone remodeling and peak bone mass, particularly in adolescents.
  • Existing research indicates that these OCs inhibit bone remodeling biochemically across age groups.

Purpose:

  • To evaluate the effect of low-dose oral contraceptives (OCs) containing Ethinyl-Estradiol (EE) on bone remodeling and bone density.
  • To assess the potential impact on peak bone mass formation in young women.
  • To explore alternative contraceptive methods for adolescents with potential skeletal health benefits.

Summary:

  • Oral contraceptives (OCs) with 20 or 30 mcg Ethinyl-Estradiol (EE) inhibit bone remodeling biochemically.

Related Experiment Videos

  • In perimenopausal women, these OCs reduce bone density loss and may increase bone density.
  • Low-dose EE OCs might impede peak bone mass in women under 20 by reducing bone metabolism, though further studies are needed.
  • Progestagen-only pills, like those with 30 mcg Levonorgestrel, may offer a viable alternative, maintaining estradiol levels sufficient for bone metabolism.

    • Impact:

    • Low-dose EE OCs may pose a risk to skeletal health and peak bone mass development in adolescents.
    • Further research is crucial to definitively assess the long-term skeletal effects of low-dose OCs in teenagers.
    • Progestagen-only pills are suggested as a potentially safer contraceptive option for adolescents, supporting normal bone metabolism and peak bone mass.
    • Adequate calcium, vitamin D, and physical activity are essential for achieving peak bone mass, independent of hormonal contraception.